Lv1
44 积分 2026-02-11 加入
Therapeutic Potential of Etrasimod in the Management of Moderately-to-Severely Active Ulcerative Colitis: Evidence to Date
2个月前
已关闭
Comment on: Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease
2个月前
已完结
Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease
2个月前
已完结
An Overview of the Mechanism of Action of the Monoclonal Antibody Vedolizumab
2个月前
已完结
The global burden of IBD: from 2015 to 2025
2个月前
已完结
Incidence of Inflammatory Bowel Disease in Urban China: A Nationwide Population-based Study
2个月前
已完结
Different levels of healing in inflammatory bowel diseases: mucosal, histological, transmural, barrier and complete healing
3个月前
已完结
Extraintestinal manifestations in inflammatory bowel disease – epidemiology, genetics, and pathogenesis
3个月前
已完结
Understanding the therapeutic toolkit for inflammatory bowel disease
3个月前
已完结
皖公网安备34019202002308
